The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · see citing works

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,869 · see citing works

IKKε and TBK1 are essential components of the IRF3 signaling pathway

Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,680 · see citing works

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

Tibes, R., Qiu, Y., Lu, Y., Hennessy, B. T., Andreeff, M., Mills, G. B., & Kornblau, S. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0334 · Cited by 722 · see citing works

Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene

Boehm, J. S., Zhao, J. J., Yao, J., Kim, S. Y., Firestein, R., Dunn, I. F., Sjostrom, S. K., Garraway, L. A., Weremowicz, S., Richardson, A. L., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.052 · Cited by 608 · see citing works

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

Wouters, B. J., Löwenberg, B., Erpelinck-Verschueren, C. A. J., van Putten, W. L. J., Valk, P. J. M., & Delwel, R. (2009) · Blood · doi:10.1182/blood-2008-09-179895 · Cited by 566 · see citing works

Y-box-binding protein 1 (YB-1) and its functions

Eliseeva, I. A., Kim, E. R., Guryanov, S. G., Ovchinnikov, L. P., & Lyabin, D. N. (2011) · Biochemistry (Moscow) · doi:10.1134/s0006297911130049 · Cited by 389 · see citing works

Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ϵ

Clark, K., Plater, L., Peggie, M. W., & Cohen, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000414 · Cited by 389 · see citing works

IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases

Shimada, T., Kawai, T., Takeda, K., Matsumoto, M., Inoue, J., Tatsumi, Y., Kanamaru, A., & Akira, S. (1999) · International Immunology · doi:10.1093/intimm/11.8.1357 · Cited by 369 · see citing works

Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity

tenOever, B. R., Ng, S., Chua, M. A., McWhirter, S. M., García‐Sastre, A., & Maniatis, T. (2007) · Science · doi:10.1126/science.1136567 · Cited by 342 · see citing works

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

Sutherland, B. W., Kucab, J. E., Wu, J., Lee, C., Cheang, M. C. U., Yorida, E., Turbin, D. A., Dedhar, S., Nelson, C. C., Pollak, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208590 · Cited by 299 · see citing works

Akt-Mediated YB-1 Phosphorylation Activates Translation of Silent mRNA Species

Evdokimova, V. E., Ruzanov, P., Anglesio, M. S., Sorokin, A. V., Ovchinnikov, L. P., Buckley, J. D., Triche, T. J., Sonenberg, N., & Sorensen, P. H. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.277-292.2006 · Cited by 259 · see citing works

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

Pardanani, A. D., Laborde, R. R., Lasho, T. L., Finke, C. M., Begna, K. H., Al‐Kali, A., Hogan, W. J., Litzow, M. R., Leontovich, A. A., Kowalski, M. M., et al. (2013) · Leukemia · doi:10.1038/leu.2013.71 · Cited by 234 · see citing works

Phosphorylation of the Tumor Suppressor CYLD by the Breast Cancer Oncogene IKKɛ Promotes Cell Transformation

Hutti, J. E., Shen, R. R., Abbott, D. W., Zhou, A. Y., Sprott, K. M., Asara, J. M., Hahn, W. C., & Cantley, L. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.031 · Cited by 229 · see citing works

IκB kinase ε and TANK-binding kinase 1 activate AKT by direct phosphorylation

Xie, X., Zhang, D., Zhao, B., Lu, M.-K., You, M., Condorelli, G., Wang, C.-Y., & Guan, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016132108 · Cited by 223 · see citing works

CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients

Pardanani, A. D., Lasho, T. L., Smith, G. D., Burns, C. J., Fantino, E., & Tefferi, A. (2009) · Leukemia · doi:10.1038/leu.2009.50 · Cited by 210 · see citing works

Inhibition of KRAS -Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit

Zhu, Z., Aref, A. R., Cohoon, T. J., Barbie, T. U., Imamura, Y., Yang, S., Moody, S. E., Shen, R. R., Schinzel, A. C., Thai, T. C., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0646 · Cited by 193 · see citing works

SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia

Puissant, A., Fenouille, N., Alexe, G., Pikman, Y., Bassil, C. F., Mehta, S. S., Du, J., Kazi, J. U., Luciano, F., Rönnstrand, L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.022 · Cited by 164 · see citing works

Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells

Basaki, Y., Hosoi, F., Oda, Y., Fotovati, A., Maruyama, Y., Oie, S., Ono, M., Izumi, H., Kohno, K., Sakai, K., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1210084 · Cited by 160 · see citing works

Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth

Barbie, T. U., Alexe, G., Aref, A. R., Li, S., Zhu, Z., Zhang, X., Imamura, Y., Thai, T. C., Huang, Y., Bowden, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75661 · Cited by 149 · see citing works

A CT promoter element binding protein: definition of a double-strand and a novel single-strand DNA binding motif

Kolluri, R., Torrey, T. A., & Kinniburgh, A. J. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.111 · Cited by 135 · see citing works

The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis

Rajurkar, M., DeJesus-Monge, W. E., Driscoll, D. R., Appleman, V. A., Huang, H., Cotton, J. L., Klimstra, D., Zhu, L., Simin, K., Xu, L., et al. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1114168109 · Cited by 119 · see citing works

Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells

Kim, J., Welsh, E. A., Oguz, U., Fang, B., Bai, Y., Kinose, F., Bronk, C. C., Rix, L. L. R., Beg, A. A., Rix, U., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220674110 · Cited by 118 · see citing works

Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?

Dolfini, D., & Mantovani, R. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.13 · Cited by 116 · see citing works

Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1

Cobbold, L. C., Wilson, L. A., Sawicka, K., King, H. A., Kondrashov, A. V., Spriggs, K. A., Bushell, M., & Willis, A. E. (2010) · Oncogene · doi:10.1038/onc.2010.31 · Cited by 106 · see citing works

Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells

Finkbeiner, M., Astanehe, A., To, K., et al. (2009) · Oncogene · doi:10.1038/onc.2008.485 · Cited by 95 · see citing works

Deregulation of IKBKE Is Associated with Tumor Progression, Poor Prognosis, and Cisplatin Resistance in Ovarian Cancer

Guo, J., Shu, S., He, L., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080767 · Cited by 91 · see citing works

Isolation of Unique STAT5 Targets by Chromatin Immunoprecipitation-based Gene Identification

Nelson, E. A., Walker, S. R., Alvarez, J. V., & Frank, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408464200 · Cited by 77 · see citing works

IKKε-Mediated Tumorigenesis Requires K63-Linked Polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 Ubiquitin Ligase Complex

Zhou, A. Y., Shen, R. R., Kim, E., Lock, Y. J., Xu, M., Chen, Z. J., & Hahn, W. C. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.031 · Cited by 75 · see citing works

IKBKE is over‐expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF‐κB

Guan, H., Zhang, H., Cai, J., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2815 · Cited by 73 · see citing works

The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival

Bommert, K., Effenberger, M., Leich, E., Küspert, M., Murphy, D. J., Langer, C., Moll, R., Janz, S., Mottok, A., Weißbach, S., et al. (2012) · Leukemia · doi:10.1038/leu.2012.185 · Cited by 62 · see citing works

IκB Kinase ε Phosphorylates TRAF2 To Promote Mammary Epithelial Cell Transformation

Shen, R. R., Zhou, A. Y., Kim, E., Lim, E., Habelhah, H., & Hahn, W. C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00468-12 · Cited by 60 · see citing works

Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical Development

Zheng, J., Xin, Y., Zhang, J., Subramanian, R., Murray, B. P., Whitney, J. A., Warr, M. R., Ling, J. R., Moorehead, L., Kwan, E., et al. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078899 · Cited by 60 · see citing works

Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer

Wei, C., Cao, Y., Yang, X., Zheng, Z., Guan, K., Wang, Q., Tai, Y., Zhang, Y., Ma, S., Cao, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316255111 · Cited by 58 · see citing works

Evaluating TBK1 as a Therapeutic Target in Cancers with Activated IRF3

Muvaffak, A., Pan, Q., Yan, H., Fernández, R., Lim, J., Dolinski, B. M., Nguyen, T. T., Strack, P. R., Wu, S., Chung, R., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0642 · Cited by 52 · see citing works

Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias

Mäkelä, E., Pavic, K., Varila, T., Salmenniemi, U., Löyttyniemi, E., Nagelli, S. G., Ammunét, T., Kähäri, V.-M., Clark, R. E., Elo, L. L., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3679 · Cited by 18 · see citing works

Multiple shRNA expressions in a single plasmid vector improve RNAi against the XPA gene

Nagao, A., Zhao, X., Takegami, T., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.078 · Cited by 11 · see citing works

Optimized Gene Silencing by Co-expression of Multiple shRNAs in a Single Vector

Ishigaki, Y., Nagao, A., & Matsunaga, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-588-0_7

Intranasal Delivery of shRNA to Knockdown the 5HT-2A receptor Enhances Memory and Alleviates AnxietyPreprint

Rohn, T. T., Radin, D. I., Brandmeyer, T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.27.573449

Potency of siRNA versus shRNA mediated knockdown in vivo

McAnuff, M. A., Rettig, G. R., & Rice, K. G. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20968 · Cited by 94 · see citing works

In Vivo Analysis of Gene Knockdown in Tetracycline-Inducible shRNA Mice

Raymond, C. S., Zhu, L., Vogt, T., & Shin, M. K. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)77021-x · Cited by 3 · see citing works